• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravitreal aflibercept for treatment of macular oedema associated with immune recovery uveitis.

作者信息

Rothova Aniki, Ten Berge Josianne C, Vingerling Johannes R

机构信息

Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Acta Ophthalmol. 2020 Nov;98(7):e922-e923. doi: 10.1111/aos.14451. Epub 2020 Apr 30.

DOI:10.1111/aos.14451
PMID:32356367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7687090/
Abstract
摘要

相似文献

1
Intravitreal aflibercept for treatment of macular oedema associated with immune recovery uveitis.玻璃体内注射阿柏西普治疗与免疫恢复性葡萄膜炎相关的黄斑水肿。
Acta Ophthalmol. 2020 Nov;98(7):e922-e923. doi: 10.1111/aos.14451. Epub 2020 Apr 30.
2
Sequential Sterile Intraocular Inflammation Associated With Consecutive Intravitreal Injections of Aflibercept and Ranibizumab.与连续玻璃体内注射阿柏西普和雷珠单抗相关的序贯性无菌性眼内炎症
Ophthalmic Surg Lasers Imaging Retina. 2017 May 1;48(5):428-431. doi: 10.3928/23258160-20170428-10.
3
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.玻璃体内注射阿柏西普治疗视网膜中央静脉阻塞所致黄斑水肿：COPERNICUS 研究 3 期的 1 年结果。
Am J Ophthalmol. 2013 Mar;155(3):429-437.e7. doi: 10.1016/j.ajo.2012.09.026. Epub 2012 Dec 4.
4
Comparison between the short-term outcomes of bevacizumab and ziv-aflibercept in the treatment of primary diabetic macular oedema.贝伐单抗与阿柏西普治疗原发性糖尿病性黄斑水肿的短期疗效比较。
Acta Ophthalmol. 2017 Dec;95(8):e803-e804. doi: 10.1111/aos.13352. Epub 2017 Jan 13.
5
Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab.雷珠单抗治疗无效的视网膜中央静脉阻塞继发黄斑水肿患者改用阿柏西普治疗的效果
Int Ophthalmol. 2018 Feb;38(1):207-213. doi: 10.1007/s10792-017-0512-8. Epub 2017 Apr 12.
6
Aflibercept-related sterile inflammation.阿柏西普相关的无菌性炎症。
Ophthalmology. 2013 May;120(5):1100-101.e1-5. doi: 10.1016/j.ophtha.2012.11.018.
7
EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.阿柏西普与雷珠单抗治疗视网膜中央静脉阻塞继发黄斑水肿的疗效及频率。
Retina. 2018 Sep;38(9):1795-1800. doi: 10.1097/IAE.0000000000001782.
8
INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR THE TREATMENT OF A PATIENT WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION.玻璃体内注射阿柏西普治疗一名继发于视网膜分支静脉阻塞的黄斑水肿患者
Retin Cases Brief Rep. 2018;12(2):93-96. doi: 10.1097/ICB.0000000000000449.
9
Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.雷珠单抗与阿柏西普治疗视网膜中央静脉阻塞相关黄斑水肿的比较。
Jpn J Ophthalmol. 2017 Jan;61(1):67-73. doi: 10.1007/s10384-016-0476-7. Epub 2016 Sep 22.
10
Three-month outcome of intravitreal ziv-aflibercept in eyes with diabetic macular oedema.玻璃体内注射阿柏西普治疗糖尿病性黄斑水肿患者的三个月疗效
Br J Ophthalmol. 2017 Feb;101(2):166-169. doi: 10.1136/bjophthalmol-2016-308679. Epub 2016 May 17.

引用本文的文献

1
Immune recovery uveitis: a focus review.免疫恢复性葡萄膜炎：重点综述。
Graefes Arch Clin Exp Ophthalmol. 2024 Aug;262(8):2703-2712. doi: 10.1007/s00417-024-06415-y. Epub 2024 Feb 21.
2
Update on the Management of Uveitic Macular Edema.葡萄膜炎性黄斑水肿的治疗进展
J Clin Med. 2021 Sep 14;10(18):4133. doi: 10.3390/jcm10184133.
3
New pharmacotherapy options for noninfectious posterior uveitis.非感染性后葡萄膜炎的新药物治疗选择。
Int Ophthalmol. 2021 Jun;41(6):2265-2281. doi: 10.1007/s10792-021-01763-8. Epub 2021 Feb 25.

本文引用的文献

1
Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor.接受抗血管内皮生长因子抑制剂玻璃体内注射前后新生血管性年龄相关性黄斑变性患者的眼内炎症细胞因子。
Sci Rep. 2018 Jan 18;8(1):1098. doi: 10.1038/s41598-018-19594-6.
2
Intravitreal Antiangiogenic Therapy of Uveitic Macular Edema: A Review.葡萄膜炎性黄斑水肿的玻璃体内抗血管生成治疗：综述
J Ocul Pharmacol Ther. 2017 May;33(4):235-239. doi: 10.1089/jop.2016.0118. Epub 2017 Feb 6.
3
Immune recovery uveitis in a patient with previously undiagnosed cytomegalovirus retinitis.一名既往未诊断出巨细胞病毒性视网膜炎的患者发生免疫恢复性葡萄膜炎。
BMJ Case Rep. 2015 Nov 3;2015:bcr2015212095. doi: 10.1136/bcr-2015-212095.
4
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.VEGF 陷阱、雷珠单抗和贝伐珠单抗与血管内皮生长因子（VEGF）及其相关配体的结合和中和作用。
Angiogenesis. 2012 Jun;15(2):171-85. doi: 10.1007/s10456-011-9249-6.
5
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.艾滋病合并巨细胞病毒性视网膜炎患者发生免疫恢复性葡萄膜炎的风险。
Ophthalmology. 2006 Apr;113(4):684-94. doi: 10.1016/j.ophtha.2005.10.067.